Ritlecitinib: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ritlecitinib. Educational only — not medical advice.
Labeled uses
LITFULO is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older. Limitations of Use : Not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine or other potent immunosuppressants.
Source: FDA labeling via NIH DailyMed (set 1882f799…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.